Table 3.

Future precision medicine in AIT

1. Precision diagnosis aided by eHealth technologies [8, 9], enhanced Component-resolved diagnostics (CRD), genomics and other future possibilities
2. Amenability of Allergic rhinitis, asthma, co-morbid allergic diseases, venom allergy, food allergy, other diseases (eg atopic dermatitis) to treatment with AIT
3. Patient stratification aided by e-HEALTH assessment and biomarkers
4. Innovative products: recombinant allergens and new forms of AIT
5. Marketing authorization for AIT products
6. A new role of preventative immunotherapy aimed at those at high risk
7. Putting the patient at the centre: guideline informed rather than guideline directed.